TXG
10X Genomics Inc
NASDAQ: TXG · HEALTHCARE · HEALTH INFORMATION SERVICES
$22.05
+9.16% today
Updated 2026-04-30
Market cap
$2.61B
P/E ratio
—
P/S ratio
4.05x
EPS (TTM)
$-0.35
Dividend yield
—
52W range
$8 – $26
Volume
2.4M
10X Genomics Inc (TXG) Financial statements
SEC filings — annual and quarterly data.
Profit margin
-6.77%
Operating margin
-9.42%
ROE
-5.78%
ROA
-6.40%
Debt/equity
—
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2017 | $71.08M | $-18.76M | 85.14% | -25.85% | -26.39% |
| 2018 | $146.31M | $-112.48M | 80.41% | -75.70% | -76.88% |
| 2019 | $245.89M | $-31.25M | 75.18% | -11.82% | -12.71% |
| 2020 | $298.85M | $-542.73M | 80.44% | -28.55% | -181.61% |
| 2021 | $490.49M | $-58.22M | 84.89% | -10.79% | -11.87% |
| 2022 | $516.41M | $-166.00M | 76.69% | -32.52% | -32.15% |
| 2023 | $618.73M | $-255.10M | 66.15% | -42.88% | -41.23% |
| 2024 | $610.78M | $-182.63M | 67.86% | -31.85% | -29.90% |
| 2025 | $642.82M | $-43.54M | 69.05% | -17.25% | -6.77% |